Health Practitioner Appointments and Medicines Act Notices




1852 NEW ZEALAND GAZETTE, No. 65 19 JUNE 2014

Appointment to the Health Practitioners Disciplinary Tribunal

Pursuant to section 86 of the Health Practitioners Competence Assurance Act 2003, the Minister of Health appoints

David Carden

as chairperson of the Health Practitioners Disciplinary Tribunal for a three-year term of office commencing on the date of this notice’s publication.

Dated at Wellington this 14th day of June 2014.

HON TONY RYALL, Minister of Health.

go3780

Reappointment to the Medical Radiation Technologists Board

Pursuant to section 120 of the Health Practitioners Competence Assurance Act 2003, the Minister of Health reappoints

Beryl Kelly

as a health practitioner member of the Medical Radiation Technologists Board for a term of office commencing on the date of this notice’s publication and ending on 1 June 2017.

Dated at Wellington this 14th day of June 2014.

HON TONY RYALL, Minister of Health.

go3782

Appointment to the Midwifery Council

Pursuant to section 120 of the Health Practitioners Competence Assurance Act 2003, the Minister of Health appoints

Joyce Croft

as a health practitioner member of the Midwifery Council for a three-year term of office commencing on the date of this notice’s publication.

Dated at Wellington this 14th day of June 2014.

HON TONY RYALL, Minister of Health.

go3783

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Galvus
Active Ingredient: Vildagliptin 50mg
Dosage Form: Tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Farmaceutica SA, Barcelona, Spain
Novartis Pharma Stein AG, Stein, Switzerland

Product: Galvus Met
Active Ingredients: Metformin hydrochloride 850mg
Vildagliptin 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Pharma Stein AG, Stein, Switzerland
Novartis Pharma Produktions GmbH, Wehr, Germany

Product: Galvus Met
Active Ingredients: Metformin hydrochloride 1000mg
Vildagliptin 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Pharma Stein AG, Stein, Switzerland
Novartis Pharma Produktions GmbH, Wehr, Germany

Product: Nevanac
Active Ingredient: Nepafenac 1mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: Alcon Laboratories (Australia) Pty Limited
Manufacturer: Alcon Laboratories Inc, Texas, United States of America

Dated this 13th day of June 2014.

STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

go3716



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2014, No 65





✨ LLM interpretation of page content

🏥 Appointment to the Health Practitioners Disciplinary Tribunal

🏥 Health & Social Welfare
14 June 2014
Health Practitioners Disciplinary Tribunal, Chairperson Appointment
  • David Carden, Appointed chairperson of the Health Practitioners Disciplinary Tribunal

  • HON TONY RYALL, Minister of Health

🏥 Reappointment to the Medical Radiation Technologists Board

🏥 Health & Social Welfare
14 June 2014
Medical Radiation Technologists Board, Health Practitioner Member Reappointment
  • Beryl Kelly, Reappointed as a health practitioner member of the Medical Radiation Technologists Board

  • HON TONY RYALL, Minister of Health

🏥 Appointment to the Midwifery Council

🏥 Health & Social Welfare
14 June 2014
Midwifery Council, Health Practitioner Member Appointment
  • Joyce Croft, Appointed as a health practitioner member of the Midwifery Council

  • HON TONY RYALL, Minister of Health

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
13 June 2014
Medicines Act 1981, New Medicines, Distribution Consent
  • STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health